A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, 2-CENTER, PILOT TRIAL OF COP 1 IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS

被引：153
|
作者：
BORNSTEIN, MB
MILLER, A
SLAGLE, S
WEITZMAN, M
DREXLER, E
KEILSON, M
SPADA, V
WEISS, W
APPEL, S
ROLAK, L
HARATI, Y
BROWN, S
ARNON, R
JACOBSOHN, I
TEITELBAUM, D
SELA, M
机构：
[1] BAYLOR UNIV,CTR NEUROSENSORY,HOUSTON,TX 77030
[2] WEIZMANN INST SCI,IL-76100 REHOVOT,ISRAEL
[3] MAIMONIDES HOSP,BROOKLYN,NY 11219
来源：
NEUROLOGY | 1991年 / 41卷 / 04期
关键词：
D O I：
10.1212/WNL.41.4.533
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：533 / 539
页数：7
相关论文
共 50 条
  • [41] N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial
    Thomas Wolfsegger
    Klaus Böck
    Wolfgang Schimetta
    Tim J. von Oertzen
    Hamid Assar
    Neurological Research and Practice, 3
  • [42] THE EFFECTS OF 4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS PATIENTS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CONCENTRATION-CONTROLLED, CROSSOVER TRIAL
    BEVER, CT
    YOUNG, D
    ANDERSON, PA
    KRUMHOLZ, A
    CONWAY, K
    LESLIE, J
    EDDINGTON, N
    PLAISANCE, KI
    PANITCH, HS
    DHIBJALBUT, S
    FOSSLER, MJ
    DEVANE, J
    JOHNSON, KP
    NEUROLOGY, 1994, 44 (06) : 1054 - 1059
  • [43] N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial
    Wolfsegger, Thomas
    Boeck, Klaus
    Schimetta, Wolfgang
    von Oertzen, Tim J.
    Assar, Hamid
    NEUROLOGICAL RESEARCH AND PRACTICE, 2021, 3 (01):
  • [44] A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis
    Wallwork, B
    Coman, W
    Mackay-Sim, A
    Greiff, L
    Cervin, A
    LARYNGOSCOPE, 2006, 116 (02): : 189 - 193
  • [45] Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
    Vena, Gino A.
    Cassano, Nicoletta
    Colombo, Delia
    Pcruzzi, Elena
    Pigatto, Paolo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) : 705 - 709
  • [46] BIASED ASSESSMENT OF BLINDING IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ORAL METHOTREXATE IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS - REPLY
    GOODKIN, DE
    ANNALS OF NEUROLOGY, 1995, 38 (05) : 832 - 833
  • [47] A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Omalizumab For Chronic Rhinosinusitis
    Mehta, N. J.
    Pinto, J.
    de Tineo, M.
    Baroody, F. M.
    Naclerio, R. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S201 - S201
  • [48] Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
    Kappos, Ludwig
    Hartung, Hans-Peter
    Freedman, Mark S.
    Boyko, Alexey
    Radue, Ernst Wilhelm
    Mikol, Daniel D.
    Lamarine, Marc
    Hyvert, Yann
    Freudensprung, Ulrich
    Plitz, Thomas
    van Beek, Johan
    LANCET NEUROLOGY, 2014, 13 (04): : 353 - 363
  • [49] INTERFERON-ALPHA AND TRANSFER-FACTOR IN THE TREATMENT OF MULTIPLE-SCLEROSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FRITH, JA
    HALLPIKE, JF
    CHAMBERS, BR
    DANTA, G
    GRAINGER, KMR
    HAMMOND, SR
    HARRIS, G
    REID, AC
    SYMINGTON, G
    WALSH, JC
    WILLIAMS, DB
    YEO, PT
    MACKAY, IR
    BASTEN, A
    BRADLEY, J
    DAWKINS, RL
    ENGLISH, D
    LOWENTHAL, RM
    VANDERBRINK, CM
    MCLEOD, JG
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (05): : 566 - 574
  • [50] INTERFERON-ALPHA AND TRANSFER-FACTOR IN THE TREATMENT OF MULTIPLE-SCLEROSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    MCLEOD, JG
    RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 125 - 130
12345